Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3315

1.

Delta Opioid Receptor Inverse Agonists and Their in vivo Pharmacological Effects.

Hirayama S, Fujii H.

Curr Top Med Chem. 2020 Apr 2. doi: 10.2174/1568026620666200402115654. [Epub ahead of print]

PMID:
32238139
2.

Dose Adjustment of Oxaliplatin Based on Renal Function in Patients With Metastatic Colorectal Cancer.

Watanabe D, Fujii H, Matsuhashi N, Iihara H, Yamada Y, Ishihara T, Takahashi T, Yoshida K, Suzuki A.

Anticancer Res. 2020 Apr;40(4):2379-2386. doi: 10.21873/anticanres.14207.

PMID:
32234941
3.

Idiopathic hypereosinophilic syndrome with formation of multiple liver mass lesions.

Ko T, Fujii H, Doi H, Fukuma T, Kadono T, Asaeda K, Kobayashi R, Nakano T, Doi T, Nakatsugawa Y, Yamada S, Nishimura T, Tomatsuri N, Sato H, Okuyama Y, Kimura H, Yoshida N.

Clin J Gastroenterol. 2020 Mar 30. doi: 10.1007/s12328-020-01113-8. [Epub ahead of print]

PMID:
32232770
4.

Delineation of the nerve fiber bundles of the infant brain associated with aging using phase difference-enhanced imaging: a preliminary study.

Fujii H, Sato N, Kimura Y, Sugiyama A, Shigemoto Y, Suzuki F, Matsuda H, Sasaki M, Sugimoto H.

Jpn J Radiol. 2020 Mar 30. doi: 10.1007/s11604-020-00955-z. [Epub ahead of print]

PMID:
32232647
5.

Evaluation of the Antifoaming Effect Using Hansen Solubility Parameters.

Kato Y, Osawa T, Yoshihara M, Fujii H, Tsutsumi S, Yamamoto H.

ACS Omega. 2020 Mar 11;5(11):5684-5690. doi: 10.1021/acsomega.9b03567. eCollection 2020 Mar 24.

6.

Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis.

Takahashi A, Moriguchi M, Seko Y, Shima T, Mitsumoto Y, Takashima H, Kimura H, Fujii H, Ishikawa H, Takaharu Y, Ishiba H, Morita A, Jo M, Nagao Y, Arai M, Hara T, Okajima A, Muramatsu A, Yoshinami N, Nakajima T, Mitsuyoshi H, Umemura A, Nishikawa T, Yamaguchi K, Okanoue T, Itoh Y.

Cancers (Basel). 2020 Mar 23;12(3). pii: E754. doi: 10.3390/cancers12030754.

7.

Migratory Aortitis Associated with Granulocyte-colony-stimulating Factor.

Shirai T, Komatsu H, Sato H, Fujii H, Ishii T, Harigae H.

Intern Med. 2020 Mar 19. doi: 10.2169/internalmedicine.4331-19. [Epub ahead of print]

8.

Incidence of severe hypoglycemia and its association with serum adiponectin in Japanese patients with type 1 and insulin-treated type 2 diabetes: the Fukuoka Diabetes Registry.

Iwase M, Komorita Y, Fujii H, Ohkuma T, Ide H, Yoshinari M, Oku Y, Higashi T, Nakamura U, Kitazono T.

J Diabetes Investig. 2020 Mar 17. doi: 10.1111/jdi.13253. [Epub ahead of print]

9.

Japanese Herbal Medicine Ninjinyoeito Mediates Its Orexigenic Properties Partially by Activating Orexin 1 Receptors.

Miyano K, Ohshima K, Suzuki N, Furuya S, Yoshida Y, Nonaka M, Higami Y, Yoshizawa K, Fujii H, Uezono Y.

Front Nutr. 2020 Feb 27;7:5. doi: 10.3389/fnut.2020.00005. eCollection 2020.

10.

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis.

Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Jsg-Nafld JSGON.

Int J Mol Sci. 2020 Mar 11;21(6). pii: E1907. doi: 10.3390/ijms21061907. Review.

11.

Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.

Fujii H, Matsuhashi N, Kitahora M, Takahashi T, Hirose C, Iihara H, Yamada Y, Watanabe D, Ishihara T, Suzuki A, Yoshida K.

Oncologist. 2020 Mar;25(3):e469-e476. doi: 10.1634/theoncologist.2019-0541. Epub 2019 Nov 20.

12.

Diphtheria in Metro Manila, the Philippines 2006-2017: A Clinical, Molecular, and Spatial Characterization.

Saito N, Dimapilis VO, Fujii H, Suzuki M, Telan EFO, Umipig DV, Solante RM, Dimapilis AQ, De Guzman F, Salva EP, Nakayama F, Toda K, Smith C, Ariyoshi K, Parry CM.

Clin Infect Dis. 2020 Mar 11. pii: ciaa005. doi: 10.1093/cid/ciaa005. [Epub ahead of print]

PMID:
32160282
13.

Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody.

Ishii Y, Fujii H, Sugimura K, Shirai T, Hoshi Y, Fujita Y, Shirota Y, Ishii T, Shimokawa H, Harigae H.

Case Rep Rheumatol. 2020 Feb 25;2020:1926908. doi: 10.1155/2020/1926908. eCollection 2020.

14.

[A Case of Gastric Cancer with Continued Progression-Free Survival Even after Total Gastrectomy and Nivolumab Therapy].

Fujii H, Choda Y, Kubota T, Ishida M, Sato D, Sumitani D, Yoshimitsu M, Nakano K, Harano M, Matsukawa H, Idani H, Shiozaki S, Okajima M.

Gan To Kagaku Ryoho. 2019 Dec;46(13):2318-2320. Japanese.

PMID:
32156917
15.

Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis.

Mutoh T, Shirai T, Ishii T, Shirota Y, Fujishima F, Takahashi F, Kakuta Y, Kanazawa Y, Masamune A, Saiki Y, Harigae H, Fujii H.

Nat Commun. 2020 Mar 9;11(1):1253. doi: 10.1038/s41467-020-15088-0.

16.

Better Retention of Abatacept Is Associated with High Rheumatoid Factor: A Five-Year Follow-Up Study of Patients with Rheumatoid Arthritis.

Okazaki S, Watanabe R, Harigae H, Fujii H.

Tohoku J Exp Med. 2020 Mar;250(3):153-159. doi: 10.1620/tjem.250.153.

17.

Treatment margins in radiotherapy for liver tumors visualized as T2*-hypointense areas on SPIO-enhanced MRI at 9.4 T.

Furuta T, Yamaguchi M, Minami M, Abe O, Fujii H.

MAGMA. 2020 Mar 4. doi: 10.1007/s10334-020-00838-4. [Epub ahead of print]

PMID:
32130567
18.

Destructive thyroiditis presenting as thyrotoxicosis followed by hypothyroidism during lenvatinib therapy for hepatocellular carcinoma.

Suoh M, Fujii H, Nagata Y, Kotani K, Hagihara A, Enomoto M, Tamori A, Inaba M, Kawada N.

Clin J Gastroenterol. 2020 Mar 3. doi: 10.1007/s12328-020-01107-6. [Epub ahead of print]

PMID:
32128670
19.

Spectroscopic Evidence for Acid-Catalyzed Disproportionation Reaction of Oxoiron(IV) Porphyrin to Oxoiron(IV) Porphyrin π-Cation Radical and Iron(III) Porphyrin.

Nishikawa K, Honda Y, Fujii H.

J Am Chem Soc. 2020 Mar 18;142(11):4980-4984. doi: 10.1021/jacs.9b13503. Epub 2020 Mar 4.

PMID:
32118413
20.

Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.

Kudo M, Okusaka T, Motomura K, Ohno I, Morimoto M, Seo S, Wada Y, Sato S, Yamashita T, Furukawa M, Aramaki T, Nadano S, Ohkawa K, Fujii H, Kudo T, Furuse J, Takai H, Homma G, Yoshikawa R, Zhu AX.

J Gastroenterol. 2020 Feb 27. doi: 10.1007/s00535-020-01668-w. [Epub ahead of print]

PMID:
32107609
21.

Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma.

Dong MP, Enomoto M, Thuy LTT, Hai H, Hieu VN, Hoang DV, Iida-Ueno A, Odagiri N, Amano-Teranishi Y, Hagihara A, Fujii H, Uchida-Kobayashi S, Tamori A, Kawada N.

Sci Rep. 2020 Feb 25;10(1):3392. doi: 10.1038/s41598-020-60440-5.

22.

Medical and Dental Visits of Chronic Kidney Disease-Diagnosed Participants Analyzed From the Specific Health Checkups Results in Japan: TAMA MED Project-CKD.

Kaneko T, Kodani E, Fujii H, Nakamura H, Sasabe H, Tamura Y, Tsuruoka S.

J Clin Med Res. 2020 Feb;12(2):115-121. doi: 10.14740/jocmr4085. Epub 2020 Feb 1.

23.

Sparse modeling of chemical bonding in binary compounds.

Kanda Y, Fujii H, Oguchi T.

Sci Technol Adv Mater. 2019 Nov 27;20(1):1178-1188. doi: 10.1080/14686996.2019.1697858. eCollection 2019.

24.

Wire-loop lesion is associated with serological immune abnormality, but not renal prognosis, in lupus nephritis.

Zoshima T, Hara S, Mizushima I, Nishioka R, Ito K, Fujii H, Yamada K, Nomura H, Kawano M.

Lupus. 2020 Feb 10:961203320905652. doi: 10.1177/0961203320905652. [Epub ahead of print]

PMID:
32041502
25.

Concomitant operation for pulmonary artery aneurysm and pulmonary valve regurgitation.

Takahashi Y, Shibata T, Sakaguchi M, Fujii H, Morisaki A, Sakon Y, Yamane K, Kishimoto N, Murakami T.

Gen Thorac Cardiovasc Surg. 2020 Feb 10. doi: 10.1007/s11748-020-01315-4. [Epub ahead of print]

PMID:
32040820
26.

Comment on: Aortarctia: a rare manifestation of relapsing polychondrits.

Shirai T, Murakami K, Fujii H, Ishii T, Harigae H.

Rheumatology (Oxford). 2020 Feb 5. pii: keaa019. doi: 10.1093/rheumatology/keaa019. [Epub ahead of print] No abstract available.

PMID:
32025723
27.

Copper-Free Huisgen Cycloaddition for the 14-3-3-Templated Synthesis of Fusicoccin-Peptide Conjugates.

Masuda R, Kawasaki Y, Igawa K, Manabe Y, Fujii H, Kato N, Tomooka K, Ohkanda J.

Chem Asian J. 2020 Feb 3. doi: 10.1002/asia.202000042. [Epub ahead of print]

PMID:
32017414
28.

Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis.

Watanabe K, Fujii H, Kono K, Goto S, Nishi S.

BMC Cardiovasc Disord. 2020 Jan 30;20(1):39. doi: 10.1186/s12872-020-01343-1.

29.

Reliability Comparison between "Distal Radius and Ulna" and "Simplified Tanner-Whitehouse III" Assessments for Patients with Adolescent Idiopathic Scoliosis.

Okuda A, Shigematsu H, Fujii H, Iwata E, Tanaka M, Morimoto Y, Masuda K, Yamamoto Y, Tanaka Y.

Asian Spine J. 2020 Jan 30. doi: 10.31616/asj.2019.0162. [Epub ahead of print]

30.

Effect of preservation on the physical and chemical properties of the temporal fascia.

Tarumoto S, Sugahara K, Hashimoto M, Hirose Y, Tsuda J, Takemoto Y, Fujii H, Matsuura T, Shimogori H, Ohgi J, Yamashita H.

Auris Nasus Larynx. 2020 Jan 23. pii: S0385-8146(19)30936-8. doi: 10.1016/j.anl.2019.12.004. [Epub ahead of print]

PMID:
31983479
31.

Transvenous embolization for a huge pelvic arteriovenous malformation associated with prominent outflow veins.

Ugajin A, Fujii H, Fujita A, Nakamura H, Fujisaki A, Sugimoto H.

Radiol Case Rep. 2020 Jan 15;15(3):285-291. doi: 10.1016/j.radcr.2019.12.013. eCollection 2020 Mar.

32.

Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.

Sugimoto K, Abe I, Minezaki M, Takashi Y, Ochi K, Fujii H, Ohishi H, Yamao Y, Kudo T, Ohe K, Abe M, Ohnishi Y, Shinagawa T, Mukoubara S, Kobayashi K.

Drug Discov Ther. 2019;13(6):322-327. doi: 10.5582/ddt.2019.01085.

33.

Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series.

Ichikawa S, Fukuhara N, Saito K, Onodera K, Shirai T, Onishi Y, Yokoyama H, Fujii H, Ichinohasama R, Harigae H.

Int J Hematol. 2020 Jan 18. doi: 10.1007/s12185-020-02822-z. [Epub ahead of print]

PMID:
31955346
34.

The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis.

Miyano K, Eto M, Hitomi S, Matsumoto T, Hasegawa S, Hirano A, Nagabuchi K, Asai N, Uzu M, Nonaka M, Omiya Y, Kaneko A, Ono K, Fujii H, Higami Y, Kono T, Uezono Y.

Sci Rep. 2020 Jan 17;10(1):625. doi: 10.1038/s41598-019-57192-2.

35.

The Effects of AHCC®, a Standardized Extract of Cultured Lentinura edodes Mycelia, on Natural Killer and T Cells in Health and Disease: Reviews on Human and Animal Studies.

Shin MS, Park HJ, Maeda T, Nishioka H, Fujii H, Kang I.

J Immunol Res. 2019 Dec 20;2019:3758576. doi: 10.1155/2019/3758576. eCollection 2019. Review.

36.

Changes in the whole/intact parathyroid hormone ratio and their clinical implications in patients with chronic kidney disease.

Okamoto K, Fujii H, Goto S, Kono K, Watanabe K, Nishi S.

J Nephrol. 2020 Jan 9. doi: 10.1007/s40620-019-00690-3. [Epub ahead of print]

PMID:
31919783
37.

Protein-losing gastroenteropathy with severe hypoalbuminemia associated with Sjögren's syndrome: A case report and review of the literature.

Akaishi T, Yasaka K, Abe M, Fujii H, Watanabe M, Shirai T, Ishizawa K, Takayama S, Kagaya Y, Harigae H, Ishii T.

J Gen Fam Med. 2019 Oct 16;21(1):24-28. doi: 10.1002/jgf2.281. eCollection 2020 Jan.

38.

Hypocomplementemia is related to elevated serum levels of IgG subclasses other than IgG4 in IgG4-related kidney disease.

Fujisawa Y, Mizushima I, Yamada K, Yamamoto M, Saeki T, Matsui S, Tsuge S, Hara S, Ito K, Fujii H, Takahashi H, Nomura H, Kawa S, Kawano M.

Mod Rheumatol. 2020 Jan 13:1-8. doi: 10.1080/14397595.2019.1709942. [Epub ahead of print]

PMID:
31903809
39.

Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin.

Watanabe D, Fujii H, Yamada Y, Iihara H, Ishihara T, Matsuhashi N, Takahashi T, Yoshida K, Suzuki A.

Anticancer Res. 2020 Jan;40(1):299-304. doi: 10.21873/anticanres.13953.

PMID:
31892580
40.

Clinical investigation of pituitary incidentalomas: A two-center study.

Ishii K, Abe I, Kameda W, Sugimoto K, Morinaga Y, Ito M, Takashi Y, Abe M, Hada Y, Takase K, Fujii H, Ohishi H, Ochi K, Yamao Y, Minezaki M, Kudo T, Higashi T, Sonoda Y, Ishizawa K, Kobayashi K.

Intractable Rare Dis Res. 2019 Nov;8(4):239-244. doi: 10.5582/irdr.2019.01083.

41.

Chorea-acanthocytosis: Time-dependent changes of symptoms and imaging findings.

Suzuki F, Sato N, Sugiyama A, Iijima K, Shigemoto Y, Morimoto E, Kimura Y, Fujii H, Takahashi Y, Nakata Y, Matsuda H, Abe O.

J Neuroradiol. 2019 Dec 13. pii: S0150-9861(19)30487-0. doi: 10.1016/j.neurad.2019.11.006. [Epub ahead of print]

PMID:
31889551
42.

Altered MR imaging findings in a Japanese female child with PRUNE1-related disorder.

Fujii H, Sato N, Takanashi JI, Kimura Y, Morimoto E, Shigemoto Y, Suzuki F, Sasaki M, Sugimoto H.

Brain Dev. 2020 Mar;42(3):302-306. doi: 10.1016/j.braindev.2019.12.001. Epub 2019 Dec 25.

PMID:
31882333
43.

Early renal dysfunction after temporary ileostomy construction.

Yaegashi M, Otsuka K, Kimura T, Matsuo T, Fujii H, Sato K, Takashimizu K, Hatanaka T, Yoshida T, Tono C, Sasaki A.

Surg Today. 2019 Dec 21. doi: 10.1007/s00595-019-01938-y. [Epub ahead of print]

PMID:
31865459
44.

Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage.

Yamada H, Kobayashi R, Shimizu S, Yamada Y, Ishida M, Shimoda H, Kato-Hayashi H, Fujii H, Iihara H, Tanaka H, Suzuki A.

Int J Clin Pract. 2020 Apr;74(4):e13464. doi: 10.1111/ijcp.13464. Epub 2019 Dec 19.

PMID:
31830345
45.

Stratification of Prognosis in Patients With Ampullary Carcinoma After Surgery by Preoperative Platelet-to-lymphocyte Ratio and Conventional Tumor Markers.

Kawaida H, Kono H, Amemiya H, Hosomura N, Watanabe M, Saito R, Maruyama S, Shimizu H, Furuya S, Akaike H, Kawaguchi Y, Sudo M, Matusda M, Itakura J, Shindo H, Takahashi EI, Takano S, Fukasawa M, Satou T, Nakazawa T, Enomoto N, Fujii H, Ichikawa D.

Anticancer Res. 2019 Dec;39(12):6923-6929. doi: 10.21873/anticanres.13913.

PMID:
31810963
46.

Effects of Medium-chain Triglycerides Administration in Chemically-induced Carcinogenesis in Mice.

Wakana H, Kono H, Fukushima H, Nakata Y, Akazawa Y, Maruyama S, Hagio K, Fujii H, Ichikawa D.

Anticancer Res. 2019 Dec;39(12):6653-6660. doi: 10.21873/anticanres.13880.

PMID:
31810930
47.

Management of intraoral bleeding in patients with Waldenström macroglobulinemia: A protocol proposal.

Ueda S, Ishii K, Fujii H, Mizutani K, Komaki K, Nagao T.

Spec Care Dentist. 2020 Jan;40(1):134-141. doi: 10.1111/scd.12440. Epub 2019 Dec 2.

PMID:
31793024
48.

Intracellular cAMP contents regulate NAMPT expression via induction of C/EBPβ in adipocytes.

Mitani T, Watanabe S, Wada K, Fujii H, Nakamura S, Katayama S.

Biochem Biophys Res Commun. 2020 Feb 12;522(3):770-775. doi: 10.1016/j.bbrc.2019.11.165. Epub 2019 Nov 30.

PMID:
31791580
49.

Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters.

Abe I, Ochi K, Takashi Y, Yamao Y, Ohishi H, Fujii H, Minezaki M, Sugimoto K, Kudo T, Abe M, Ohnishi Y, Mukoubara S, Kobayashi K.

Medicine (Baltimore). 2019 Nov;98(47):e18067. doi: 10.1097/MD.0000000000018067.

50.

Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.

Fujii H, Matsuhashi N, Kitahora M, Takahashi T, Hirose C, Iihara H, Yamada Y, Watanabe D, Ishihara T, Suzuki A, Yoshida K.

Oncologist. 2019 Nov 20. pii: theoncologist.2019-0541. doi: 10.1634/theoncologist.2019-0541. [Epub ahead of print]

Supplemental Content

Support Center